| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/29/2009 | CN101417071A Daylily enema for treating prostate disease and preparation method thereof |
| 04/29/2009 | CN101417040A Traditional Chinese medicine decoction for reinforcing kidney to replenish kidney essence |
| 04/29/2009 | CN101417014A Traditional Chinese medicine composition for treating stramgutia and preparation method and quality control method thereof |
| 04/29/2009 | CN101416992A Beggarticks dispersion tablets and preparation method thereof |
| 04/29/2009 | CN101416957A Use of resveratrol or naringenin in preventing and treating diabetic nephropathy |
| 04/29/2009 | CN101416947A Compound alpha-ketoacid chewing tablet and preparation method thereof |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482665C Pyrazolo 1,5-a pyrimidine derivatives |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482651C Diaminothiazoles |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/29/2009 | CN100482281C Method of treatment using anti-ErbB antibody-maytansinoid conjugates |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482254C Method for extracting effective site of Xanthoceras sorbifolia hulled seed |
| 04/29/2009 | CN100482249C Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat nephrotic syndrome |
| 04/29/2009 | CN100482248C Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat diabetic nephropathy |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524817 Osteogenic protein/bone morphogenetic proteins of eukaryotic origin |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | CA2425704C Tissue-specific exogenous optical agents |
| 04/28/2009 | CA2380074C Novel amide derivatives |
| 04/28/2009 | CA2334761C Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use |
| 04/23/2009 | WO2009052310A1 A3 adenosine receptor antagonists |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105298 Pharmaceutical composition for therapy of interstitial cystitis |
| 04/23/2009 | US20090105222 Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 04/23/2009 | US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells |
| 04/23/2009 | US20090104154 Composition and method for killing of tumours |
| 04/23/2009 | CA2702699A1 Csf-1r inhibitors compositions, and mthods of use |
| 04/23/2009 | CA2702644A1 A3 adenosine receptor antagonists |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050739A1 Quinazoline derivative |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049893A2 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2048948A2 Liquid compositions of calcium acetate |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | EP1299727B1 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/22/2009 | CN101415690A Novel tricyclic dihydropyrazines as potassium channel openers |
| 04/22/2009 | CN101415678A Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 04/22/2009 | CN101412690A Medicinal acid addition salt of silodosin, and preparation and medicament use thereof |
| 04/22/2009 | CN101411833A Dragon's blood extract as well as preparation method and application thereof |
| 04/22/2009 | CN101411807A Health-care medicinal liquor with function for tonifying kidney and preparation method thereof |
| 04/22/2009 | CN101411481A Medicinal food for tonifying kidney, replenishing vital essence and tonifying bone |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100479805C Chinese caterpillar fungus injection preparation method |
| 04/22/2009 | CN100479804C Tibet medicine lamivphlomis root injection preparation and preparing method thereof |
| 04/21/2009 | US7521570 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | CA2532330C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation |
| 04/16/2009 | WO2009047903A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | WO2009046606A1 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 04/16/2009 | WO2009027994A3 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 04/16/2009 | WO2008157060A3 Human umbilical tissue-derived cell compositions for the treatment of incontinence |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090099241 Pharmaceutical composition containing antihypertensive agents |
| 04/16/2009 | US20090099223 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 04/16/2009 | US20090099195 Therapeutic Compounds 570 |
| 04/16/2009 | US20090099184 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 04/16/2009 | US20090099140 20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | DE102007049157A1 New substituted 2,3-dihydro-(1,2,3)triazol-4-one compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, inflammatory disease and anemia |
| 04/16/2009 | DE102007048447A1 New substituted dihydropyrazole-3-thione compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, wound healing and anemia |
| 04/16/2009 | CA2701880A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2048132A1 Tetrahydro-naphthalene and urea derivatives |
| 04/15/2009 | EP2047864A1 Use of rpn2 gene expression inhibitor |
| 04/15/2009 | EP2047862A1 Remedy for renal disease |
| 04/15/2009 | EP2046775A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 04/15/2009 | EP2046333A2 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 04/15/2009 | EP2046327A1 Medical use of cyclin dependent kinases inhibitors |
| 04/15/2009 | EP2046323A2 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 04/15/2009 | EP1419143B1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410369A Process for the preparation of tamsulosin and related compounds |
| 04/15/2009 | CN101407506A Benzofuran derivatives and uses thereof |
| 04/15/2009 | CN101406692A Vaccine composition containing transforming growth factor alpha |
| 04/15/2009 | CN101406681A Chinese medicinal toxin-expelling decoction for uraemia |
| 04/15/2009 | CN101406667A Liquid medicine for relieving middle and discharging calculi |
| 04/15/2009 | CN101406665A Chinese medicament preparation for discharging calculus in vivo |
| 04/15/2009 | CN101406610A Chinese patent medicinal powder for treating anuria and vomiting and preparation method thereof |
| 04/15/2009 | CN101406605A Granule for treating prostatitis containing six ingredients |